NCT00147732View on ClinicalTrials.gov

Randomized Trial of ARCON in Larynx Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2013

Conditions
Larynx Carcinoma
Interventions
RADIATION

Accelerated radiotherapy

68 Gy over 5.5 weeks

RADIATION

ARCON

68 Gy over 5.5 weeks Carbogen: 98% oxygen plus 2% carbon dioxide Nicotinamide 60 mg/kg daily

Trial Locations (7)

Unknown

Free University Medical Centre, Amsterdam

University Medical Centre Groningen, Groningen

Leids University Medical Centre, Leiden

Maastro Clinic, Maastricht

University Medical centre Utrecht, Utrecht

Mount Vernon Hospital, Northwood

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

lead

Radboud University Medical Center

OTHER

NCT00147732 - Randomized Trial of ARCON in Larynx Cancer | Biotech Hunter | Biotech Hunter